Lymphopenia / immunoparalysis in critically ill adults

Clinical trials for Lymphopenia / immunoparalysis in critically ill adults explained in plain language.

Never miss a new study

Get alerted when new Lymphopenia / immunoparalysis in critically ill adults trials appear

Sign up with your email to follow new studies for Lymphopenia / immunoparalysis in critically ill adults, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Immune boosting study for severe pneumonia pulled before start

Disease control Cancelled

This study was designed to see if adding two immune treatments (NAI and iNKT cells) to standard care could help critically ill adults with severe pneumonia, sepsis, or lung failure recover. It planned to enroll ICU patients and follow them for 90 days. However, the study was with…

Matched conditions: LYMPHOPENIA / IMMUNOPARALYSIS IN CRITICALLY ILL ADULTS

Phase 2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:30 UTC

Lymphopenia / immunoparalysis in critically ill adults

Get alerted when new Lymphopenia / immunoparalysis in critically ill adults trials appear

Immune boosting study for severe pneumonia pulled before start